SGLT2i, Pioglitazone, and Ketone Production in T1D

Abroad (travel likely)RecruitingPHASE3

Conditions

Type1diabetes

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Texas Diabetes Institute, San Antonio, Texas, United States
Contact: Study coordinator (Ralph Defronzo, MD) · defronzo@uthscsa.edu · 210-567-6691
Contact: Study coordinator (Aurora Merovci, MD, MPH) · merovci@uthscsa.edu · 210 358 7409

Study leads

Muhammad Abdul-Ghani, MD
Principal Investigator
The University of Texas Health Science Center at San Antonio
Ralph DeFronzo, MD
Principal Investigator
The University of Texas Health Science Center at San Antonio

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tirzepatide Use in People With Obesity and Type 1 Diabetes

Type1diabetes · Obesity

Abroad (travel likely)RecruitingPHASE4

Kuwait City, Kuwait

Thrive With Type 1 Diabetes 2026

Type1diabetes

Abroad (travel likely)Recruiting

Atlanta, United States · Atlanta, United States

Evaluation of the Accuracy and Safety of A Novel Real-Time Continuous Glucose Monitoring System

Type1diabetes

Abroad (travel likely)Recruiting

Luoyang, China

Exercise Training and Endothelial Function in Type 1 Diabetes

Type1diabetes

Abroad (travel likely)Recruiting

Lille, France